Evidence map›Paper›PMID 30567818›Full record

ArticleBMJ open2018

Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation.

Andrew James Williams, William Henley, John Frank

Abstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. The impact of prescription drug co-payments for publicly insured families.The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew James WilliamsEuropean Centre for Environment and Human Health, College of Medicine and Health, University of Exeter, Truro, UK.ORCID 0000-0002-2175-8836
William HenleyInstitute of Health Research, College of Medicine and Health, University of Exeter, Exeter, UK.
John FrankScottish Collaboration for Public Health Research and Policy, University of Edinburgh, Edinburgh, UK.

Funding

Arthritis Research UKBritish Heart FoundationCancer Research UKChief Scientist OfficeMedical Research Council MR/K007017/1Medical Research Council MR/K023209/1
6 · The paper itself

Abstract

objectivesTo identify whether the abolition of prescription fees in Scotland resulted in: (1) Increase in the number (cost to NHS) of medicines prescribed for which there had been a fee (inhaled corticosteroids). (2) Reduction in hospital admissions for conditions related to those medications for which there had been a fee (asthma or chronic obstructive pulmonary disease (COPD))-when both are compared with prescribed medicines and admissions for a condition (diabetes mellitus) for which prescriptions were historically free.

designNatural experimental retrospective general practice level interrupted time series (ITS) analysis using administrative data.

settingGeneral practices, Scotland, UK.

participants732 (73.6%) general practices across Scotland with valid dispensed medicines and hospital admissions data during the study period (July 2005-December 2013).

interventionReduction in fees per dispensed item from April 2008 leading to the abolition of the fee in April 2011, resulting in universal free prescriptions. PRIMARY AND SECONDARY OUTCOMES: Hospital admissions recorded in the Scottish Morbidity Record - 01 Inpatient (SMR01) and dispensed medicines recorded in the Prescribing Information System (PIS).

resultsThe ITS analysis identified marked step reductions in adult (19-59 years) admissions related to asthma or COPD (the intervention group), compared with older or young people with the same conditions or adults with diabetes mellitus (the counterfactual groups). The prescription findings were less coherent and subsequent sensitivity analyses found that both the admissions and prescriptions data were highly variable above the annual or seasonal level, limiting the ability to interpret the findings of the ITS analysis.

conclusionsThis study did not find sufficient evidence that universal free prescriptions was a demonstrably effective or ineffective policy, in terms of reducing hospital admissions or reducing socioeconomic inequality in hospital admissions, in the context of a universal, publicly administered medical care system, the National Health Service of Scotland.

Indexed as

Prescription FeesAdolescentAdultAsthmaDatabases, FactualDrug PrescriptionsGlucocorticoidsHumansInterrupted Time Series AnalysisMiddle AgedPatient AdmissionPulmonary Disease, Chronic ObstructiveRetrospective StudiesScotlandUniversal Health InsuranceYoung AdultGlucocorticoidsadministrative dataco-paymentfees, pharmaceuticalinterrupted time seriesnatural experimentquasi-experimental

Identifiers

PMID30567818
PMCPMC6303621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.